Feasibility study of weekly paclitaxel patients with pre-treatment (2 regimens) advanced/recurrent gastric cancer (OGSG 0602)

Not Applicable

• Conditions: Advanced / Recurrent gastric cancer.

• Registration Number: JPRN-UMIN000000723
• Lead Sponsor: OGSG

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-06-01
• Study Completion: 2009-09-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

Not provided

Exclusion Criteria

1. cavity fluid which should be taken out 2. with double cancer and/or multiple cancer 3. patients with disorders on peripheral nerves 4. with active infectious disease which needs treatment 5. under the condition of diarrhea 6. with some mental and/or neural disorder which disturbs registration 7. under continuous steroids therapy 8. with other severe diseases(intestinal paralysis, intestinal obstruction, uncontrolled DM, pulmonary fibrosis, cardiac failure, or liver dysfunction) 9. pregnant and/or nursing women 10.with allergic history against medicines 11.with severe allergic response against medicine including cremoful 12.under Docetaxel or Paclitaxel therapy 13.doctors' stop not to register to the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified